Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability. Issue 1 (March 2015)
- Record Type:
- Journal Article
- Title:
- Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability. Issue 1 (March 2015)
- Main Title:
- Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability
- Authors:
- Viener, Hilla-Lee
Gorbatov, Rostic
Vardi, Moshe
Doros, Gheorghe
Miller-Lotan, Rachel
Zohar, Yaniv
Sabo, Edmond
Asleh, Rabea
Levy, Nina S.
Goldfarb, Levi J.
Berk, Thomas A.
Haas, Tali
Shalom, Hadar
Suss-Toby, Edith
Kam, Adi
Kaplan, Marielle
Tamir, Ronit
Ziskind, Anna
Levy, Andrew P. - Abstract:
- Abstract: Objective: Homozygosity for a 1.7 kb intragenic duplication of the Haptoglobin (Hp) gene (Hp 2-2 genotype), present in 36% of the population, has been associated with a 2–3 fold increased incidence of atherothrombosis in individuals with Diabetes (DM) in 10 longitudinal studies compared to DM individuals not homozygous for this duplication (Hp 1-1/2-1). The increased CVD risk associated with the Hp 2-2 genotype has been shown to be prevented with vitamin E supplementation in man. We sought to determine if there was an interaction between the Hp genotype and vitamin E on atherosclerotic plaque growth and stability in a transgenic model of the Hp polymorphism. Methods and Results: Brachiocephalic artery atherosclerotic plaque volume was serially assessed by high resolution ultrasound in 28 Hp 1-1 and 26 Hp 2-2 mice in a C57Bl/6 ApoE −/− background. Hp 2-2 mice had more rapid plaque growth and an increased incidence of plaque hemorrhage and rupture. Vitamin E significantly reduced plaque growth in Hp 2-2 but not in Hp 1-1 mice with a significant pharmacogenomic interaction between the Hp genotype and vitamin E on plaque growth. Conclusions: These results may help explain why vitamin E supplementation in man can prevent CVD in Hp 2-2 DM but not in non Hp 2-2 DM individuals. Highlights: Plaque volume can be assessed serially in the same mouse over time by high resolution ultrasound. Hp genotype is a determinant of atherosclerotic plaque volume growth development. Hp 2-2Abstract: Objective: Homozygosity for a 1.7 kb intragenic duplication of the Haptoglobin (Hp) gene (Hp 2-2 genotype), present in 36% of the population, has been associated with a 2–3 fold increased incidence of atherothrombosis in individuals with Diabetes (DM) in 10 longitudinal studies compared to DM individuals not homozygous for this duplication (Hp 1-1/2-1). The increased CVD risk associated with the Hp 2-2 genotype has been shown to be prevented with vitamin E supplementation in man. We sought to determine if there was an interaction between the Hp genotype and vitamin E on atherosclerotic plaque growth and stability in a transgenic model of the Hp polymorphism. Methods and Results: Brachiocephalic artery atherosclerotic plaque volume was serially assessed by high resolution ultrasound in 28 Hp 1-1 and 26 Hp 2-2 mice in a C57Bl/6 ApoE −/− background. Hp 2-2 mice had more rapid plaque growth and an increased incidence of plaque hemorrhage and rupture. Vitamin E significantly reduced plaque growth in Hp 2-2 but not in Hp 1-1 mice with a significant pharmacogenomic interaction between the Hp genotype and vitamin E on plaque growth. Conclusions: These results may help explain why vitamin E supplementation in man can prevent CVD in Hp 2-2 DM but not in non Hp 2-2 DM individuals. Highlights: Plaque volume can be assessed serially in the same mouse over time by high resolution ultrasound. Hp genotype is a determinant of atherosclerotic plaque volume growth development. Hp 2-2 plaques have more unstable features including more iron, thinner caps and more hemorrhage. Vitamin E is decreased in Hp 2-2 plasma. Vitamin E can prevent plaque volume growth in Hp 2-2 mice. … (more)
- Is Part Of:
- Atherosclerosis. Volume 239:Issue 1(2015)
- Journal:
- Atherosclerosis
- Issue:
- Volume 239:Issue 1(2015)
- Issue Display:
- Volume 239, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 239
- Issue:
- 1
- Issue Sort Value:
- 2015-0239-0001-0000
- Page Start:
- 232
- Page End:
- 239
- Publication Date:
- 2015-03
- Subjects:
- Diabetes -- Haptoglobin -- Vitamin E -- Pharmacogenomics -- Brachiocephalic artery plaque
Arteriosclerosis -- Periodicals
Electronic journals
616.136 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.atherosclerosis.2015.01.008 ↗
- Languages:
- English
- ISSNs:
- 0021-9150
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21875.xml